Dune Medical Devices Receives FDA Approval for Breakthrough Advancement in Breast Cancer Surgery

Dune Medical Devices announced that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) from the FDA.
MarketWatch